Clinical and Experimental Pharmacology and Physiology: Introduction

Clinical and Experimental Pharmacology and Physiology

Volumn 34, Issue 7, 2007, Pages 645-646

  McGrath, Barry P ^a   Laurent, Stéphane ^b  

^a MONASH UNIVERSITY   (Australia)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; ESTROGEN; GESTAGEN; METFORMIN; SEX HORMONE; BIOLOGICAL MARKER;

ARTERY CALCIFICATION; ARTERY COMPLIANCE; ARTERY DILATATION; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DISEASE COURSE; DISEASE MARKER; DRUG EFFECT; EDITORIAL; HEREDITY; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LOW DRUG DOSE; MENOPAUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OVARY POLYCYSTIC DISEASE; PULSE PRESSURE; PULSE WAVE; SYSTOLIC HYPERTENSION; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; ANIMAL; ARTERY; ARTICLE; BLOOD; PATHOPHYSIOLOGY; PROGNOSIS;

ANIMALS; ARTERIES; BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; HUMANS; PROGNOSIS; TREATMENT OUTCOME;

EID: 34250714385     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04653.x     Document Type: Editorial

References (19)

1. Mahomed FA. The physiological and clinical use of the sphygmograph. Med. Times Gazette 1872 1 : 62 3.
2. Bramwell JC, Hill AV. Velocity of transmission of the pulse-wave and elasticity of the arteries. Lancet 1922 i : 891 2.
3. McGrath BP, Liang Y-L, Kotsopoulos D, Cameron JD. Impact of physical and physiological factors on arterial function. Clin. Exp. Pharmacol. Physiol. 2001 28 : 1104 7.
4. Laurent S, Cockcroft J, Van Bortel L et al. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur. Heart J. 2006 27 : 2588 605.
5. Zoungas S, Asmar R. Arterial stiffness and cardiovascular outcome. Clin. Exp. Pharmacol. Physiol. 2007 34 : 647 51.
6. Kingwell B, Boutouyrie P. Genetic influences on the arterial wall. Clin. Exp. Pharmacol. Physiol. 2007 34 : 652 7.
7. Hayward CS, Benetos A. Hereditary and environmental influences on arterial function. Clin. Exp. Pharmacol. Physiol. 2007 34 : 658 64.
8. McEniery C, Wilkinson I, Avolio A. Age, hypertension and arterial function. Clin. Exp. Pharmacol. Physiol. 2007 34 : 665 71.
9. Mitchell GF, Parise H, Benjamin EJ et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: The Framingham heart study. Hypertension 2004 43 : 1239 45.
10. Fantin F, Mattocks A, Bulpitt CJ, Banya W, Rakikumar C. Is augmentation index a good measure of vascular stiffness in the elderly? Age Ageing 2006 36 : 43 8.
11. Teede H. Sex hormones and the cardiovascular system: Effects on arterial function in women. Clin. Exp. Pharmacol. Physiol. 2007 34 : 672 6.
12. Worboys S, Kotsopoulos D, Teede H, McGrath BP, Davis S. Evidence that parenteral testosterone therapy may improve endothelium-dependent and independent vasodilation in postmenopausal women already receiving estrogen. J. Clin. Endocrinol. 2001 86 : 158 61.
13. Cameron J, Cruickshank K. Glucose, insulin, diabetes and mechanisms of arterial dysfunction. Clin. Exp. Pharmacol. Physiol. 2007 34 : 677 82.
14. Meyer C, McGrath BP, Teede H. Overweight women with polycystic ovarian syndrome have evidence of subclinical cardiovascular disease. J. Clin. Endocrinol. Metab. 2005 90 : 5711 16.
15. Meyer C, McGrath BP, Teede H. Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovarian syndrome. Diabetes Care 2007 30 : 471 8.
16. Cruickshank K, Riste 1, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intorlerance: An integrated index of vascular function? Circulation 2002 106 : 2085 90.
17. Lacy PS, O'Brien DG, Stanley AG, Dewar MM, Swales PPR, Williams B. Increased pulse wave velocity is not associated with elevated augmentation index in patents with diabetes. J. Hypertens. 2004 22 : 1937 44.
18. Kerr P, Guerin A. Arterial calcification and stiffness in chronic kidney disease. Clin. Exp. Pharmacol. Physiol. 2007 34 : 683 7.
19. Hope SA, Hughes AD. Drug effects on the mechanical properties of large arteries in humans. Clin. Exp. Pharmacol. Physiol. 2007 34 : 688 93.